Medicine of the Future in America

Tag Archives: antibiotics

Canadian Antibiotics: All You Need to Know


Canadian Antibiotics: how they work?

Antibiotics are special substances of biological origin that can suppress the growth of viruses, bacteria and microorganisms or completely destroy them. The specificity of antibiotics action is the main feature. That is, each specific type of pathogen microorganisms is susceptible not to every type of antibiotics. This feature is the basis of the main modern antibiotics classification: narrow-spectrum antibiotics (suppress the vital activity of bacteria of one type) and broad-spectrum antibiotics (destroy various types of microorganisms). You may buy antibiotics online at My Canadian Pharmacy Team  at reasonable price and convenient conditions (Amoxicillin, Zithromax, Cipro, Tetracycline and many others).

Antibiotics are designed to help a person overcome the infection, but it is very important not to cause additional harm to your health. Uncontrolled intake of such drugs is unacceptable, as it may have serious complications. Antibiotics should be prescribed by a doctor and taken under his strict control.

When it is necessary to use an antibiotic?

antibioticsAntibiotic is a drug which kills bacteria. Therefore, an indication for their use is the presence of a pathological process in the organism, caused by bacteria. In extremely rare cases and on doctor’s advice, antibiotics can be used as a preventative measure.

Before prescribe antibiotics, you must make sure that the disease is caused by bacteria, not by other microorganisms. Most often, a usual general blood analysis helps find it out – the number of white blood cells increases in case of a bacterial infection. But sometimes it is required to determine not only the presence of bacteria, but their specific form for more precise selection of antibiotics and more effective treatment. Doctors usually conduct additional examinations that allow to determine bacteria types.

Usually, Canadian antibiotics are used for the treatment of:

  • Bacterial pneumonia;
  • infections of the genitourinary system;
  • purulent inflammation of the skin;
  • sexually transmitted infections.

But many people practice antibiotics therapy for any colds that is fundamentally wrong. Any cold is a severe acute respiratory syndrome (SARS), caused by viruses, which antibiotics do not affect in any way.

When antibiotics are not necessary

Most people are fans of self-treatment. At the same time, they just can not explain what antibiotic is and believe that it is just a strong medicine that treat everything. That is why they often prescribe antibiotics themselves when these drugs are not necessary at all. The most common situations are high temperature treatment, SARS and prophylactic administration.

Increased body temperature is a unique defensive reaction of the organism, it can be caused by both viral or bacterial infections, an autoimmune process, tumors and even simple exhaustion. Therefore, you can’t just start taking an antibiotic when the temperature rises, there is a small possibility of a bacterial infection, sensitive to the drug, and the list of antibiotics side effects is rather big. Higher temperatures may be reduced bu antipyretic drugs, not antibiotics.

Antibiotics and microflora

You already know that the basis of antibiotics action is the suppression and destruction of microorganisms. Our organism together with its microflora form a stable homeostasis. Thus, quality of our life is regulated by the balance of all these processes. Any antibiotic is an inhibitor suppressing chemical reactions including beneficial microbes, which adversely affects the homeostasis.

In simple words, antibiotics provide a kind of temporary sterility. In this environment, none microorganism can survive except pathogenic microbes, and this can lead to the development of numerous pathologies. It is a mistake to believe that the microflora is able to quickly recover from such an impact. That is why our doctors, prescribing antibiotics to patients, also prescribe drugs supporting the intestinal microflora.

Antibiotics safe in pregnancy?

 pregnant womenAntibiotics during pregnancy is quite complicated and controversial topic. Of course, you know that it’s generally undesirable for women to take any medicines in this period, but what if the body has to deal with a serious infection that threatens the fetus? My Canadian Pharmacy professional team does not recommend antibiotic treatment for pregnant women without serious evidence for antibiotics need. These may be sexual infections, pyelonephritis, pneumonia, etc.

Prescribing antibiotics, doctors must take the period of gestation into account. It is undesirable to use antibiotics in the first trimester, when there is a formation of the vital organs of the fetus. In this case, antibacterial agents can damage organs and functions of the child, causing birth defects. If the treatment of the mother is necessary, physicians should provide strict control over the treatment process to remove the drug in the event of the slightest complications.

If you had to take a course of antibiotics before pregnancy, but you want to conceive, it is better to postpone pregnancy for two or three months. However, if the pregnancy is unplanned, do not worry: antibiotics taken before the delay of menstruation are unlikely to adversely affect the health of your child.

How to take antibiotics without harm to health? My Canadian pharmacy advice

doctorAntibiotic is not a candy, but a serious medication that can cause very serious consequences:

  • Allergic reactions;
  • problems with the gastrointestinal tract;
  • kidneys problems;
  • liver functions violation;
  • intestinal dysbiosis (a frequent antibiotics side effect);
  • neurological disorders (less common antibiotics side effect).

* My Canadian Pharmacy reminds, usually unpleasant consequences occur not because of the low quality drug or a bad doctor, but because the patient takes antibiotics in a wrong manner.

To avoid most antibiotics side effects, follow the doctor’s recommendations and instructions for use.

In case of any allergic reactions it is necessary to discontinue treatment and look for other options.

Treatment of dysbiosis is often carried out with probiotics. But in fact it is not necessary in most cases – as a rule patients just need a correct nutrition to cope with this problem.


  • You can not sunbathe during Tetracycline therapy and 2 weeks after the end of the course;
  • you can’t paint or curl hair during and after antibiotics course;
  • tetracyclines, penicillins and rifampin reduce the effectiveness of oral contraceptives;
  • blood thinners are not taken simultaneously with antibiotics of penicillin and cephalosporin groups to avoid bleeding.

If you take the appropriate antibiotic and follow all the rules, the harm from the drug will be minimal and treatment will be quick and easy.

* Aviod antibiotics overuse.

You must consult your doctor immediately in the following cases:

  • Antibiotics cause allergic reactions;
  • there is no health improvement;
  • new pathological symptoms.

So, you can see, antibiotics are quite “treacherous” drugs. On the one hand, you can’t go without them, but on the other – it’s very difficult to recover after treatment. If you have an urgent need and your doctor prescribed a particular antibiotic to you, follow all the doctor’s directions and do not stop treatment even if you notice rapid improvement.

Preventing Ventilator-Associated Pneumonia in Adults: Sedation and Weaning

Preventing Ventilator-Associated Pneumonia in Adults: Sedation and WeaningThere have been conflicting reports on the use and benefits of heat/moisture exchangers (HMEs) compared to heated humidifiers for preventing VAP. A recent metaanalysis by Kola and cowork-ers demonstrated a reduction in the relative risk of developing VAP in the HME group (relative risk, 0.7; 95% CI, 0.5 to 0.04) but may have been affected by the large difference in the outcomes in one of the studies. For patients with a mean ventilation duration > 7 days, the relative risk for VAP fell to 0.57 in the HME group (95% CI, 0.38 to 0.83). A more recent, large, randomized study by Lacherade and coworkers found no benefit for the HME group. In another study of HMEs using historical control subjects, patients who received mechanical ventilation > 2 days reported a significant reduction in VAP (p = 0.01).
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Sedation and Weaning

Efforts to reduce acute lung injury by using smaller tidal volumes and lower pressures have been suggested along with sedation vacations to facilitate weaning. Recently, Schweickert and coworkers evaluated seven complications in 128 patients receiving mechanical ventilation and continuous infusions of sedative drug who were randomized to daily interruption of sedative infusions (n = 66) vs sedation directed by the medical ICU team without this strategy (n = 60). Daily interrupted sedative infusions reduced ICU length of stay (6.2 days vs 9.9, p < 0.01), duration of mechanical ventilation (4.8 vs 7.3 days, p < 0.003), and the incidence of complications per patient (13 complications in 12 patients vs 26 complications in 19 patients, p < 0.04).
Weaning protocols are recommended to limit the duration of mechanical ventilation. Dries and co-workers, using a standardized weaning protocol, reduced days of mechanical ventilation (ventilator days/ICU days) from 0.47 to 0.33, numbers of patients failing ventilation (25 vs 43), and reduced rates of VAP (15% to 5%). Although there are a number of confounding variables with the study design, efforts to remove the endotracheal tube without reintubation should be encouraged.
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Noninvasive Positive Pressure Ventilation

Preventing Ventilator-Associated Pneumonia in Adults: Noninvasive Positive Pressure VentilationNoninvasive positive pressure ventilation (NPPV) provides ventilatory support without the need for intubation and for earlier removal of the endotracheal tube to reduce complications related to prolonged intubation. Burns and coworkers, in a recent Cochrane review, reported significant benefits: decreased mortality (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.22 to 0.76), lower rates of VAP (RR 0.28; 95% CI, 0.0.90 to 0.85); decreased length of ICU and shorter hospital stays; and lower duration of mechanical support. The impact of NPPV is greater in patients with COPD exacerbations or congestive heart failure than for patients with VAP. Recent data also indicate that NPPV may not be a good strategy to avoid reintubation after initial extubation, and is recommended for hospitals with staff who are experienced in this technique.
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Lactobacillus GG

This impressive result for an inexpensive, nontoxic, topically applied modality warrants further attention but is difficult to reconcile with the absence of effect on ventilator-days, length of stay, or mortality. It is important to measure how prophylactic use of chlorhexidine and chlorhexidine-colistin complement other effective prevention strategies, and resistance could become an important issue over time. so
Iseganan, a topical antimicrobial peptide, active against aerobic and anaerobic Gram-positive and Gram-negative bacteria and yeasts, was evaluated in a randomized, double-bind trial to prevent VAP. Although there was a significant reduction in colonization in the treatment group, the rate of VAP among survivors (16% vs 20%) and 14-day morality was similar (22% vs 18%). Although protegrins are ubiquitous antimicrobial peptides, and in human trials were able to reduce oral colonization by two logs, these results raise several questions about ise-ganan efficacy and why it failed.
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Transfusion Risk

Preventing Ventilator-Associated Pneumonia in Adults: Transfusion RiskAlthough transfusion was suggested as a risk factor of nosocomial infection and a modifiable risk factor for VAP in the American Thoracic Society/Infectious Diseases Society of America guideline, in a secondary analysis from a recent, large study of transfusions, it was identified as an independent risk factor for VAP. This may become a more important modifiable risk factor, as recent data from Levy and coworkers reported that patients receiving mechanical ventilation received transfusions at a higher pretransfusion hemoglobin level than patients not receiving mechanical ventilation (8.7 vs 8.2, p < 0.0001).
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Enteral Feeding Protocol

There were also questions on the generalizability of ITT to medical ICU patients. In a recent randomized study of 1,200 medical ICU patients, ITT did not significantly reduce hospital mortality overall, and increased mortality in patients with ICU stays < 3 days. However, the ITT group had reduced acquired renal failure, duration of mechanical ventilation, and length of ICU and hospital stay. Difficulty in predicting length of stay is difficult; concerns about the risks of hypoglycemia, resource implications, and assessing the benefit of ITT in different hospitals require further evaluation. canadian pharmacy
Enteral feeding is preferred to parenteral feeding, but aspiration pneumonia is a complication. Bowman and coworkers instituted an evidence-based, enteral feeding protocol in which 78 to 85% of patients reached their enteral feeding goal and aspiration pneumonia rates decreased from 6.8 to 3.2/1,000 patient days. Such protocols should be reviewed by multidisciplinary committees to standardize enteral nutrition protocols and risk reduction for VAP.
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Patient Position

Preventing Ventilator-Associated Pneumonia in Adults: Patient PositionIn contrast to rotational beds, semirecumbent patient position is a low-cost, easily accessible intervention, and may be a more practical and more tolerable approach than rotational beds or prone body position. Maintaining patients who are receiving mechanical ventilation or who are enterally fed in a 30° to 45° semirecumbent position, particularly during enteral feeding, continues to be strongly recommended based on the VAP reduction in one randomized study. so
A more recent study by van Nieuwenhoven et al, in which patients receiving mechanical ventilation were randomly assigned to backrest elevation of 45° vs the standard of 10°, demonstrated barriers to implementing this strategy. Backrest elevation was measured continuously during the first week of ventilation with a monitoring device. The targeted backrest elevation of 45° was not reached; the actual achieved difference was 28° vs 10°, which did not reduce VAP. Similarly, Grap and Munro monitored patient position in ICU patients using a bed frame elevation gauge or electronic bed readout and found very low compliance with maintaining semirecum-bent patient position, with a mean backrest elevation of only 19.2° with 70% of subjects maintained in a supine position. Maintaining patients receiving mechanical ventilation or who are enterally fed in a semirecumbent position may need to evaluate more realistic targets.
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Infection Control

Infection control programs have repeatedly demonstrated efficacy in reducing infection rates and in controlling the spread of MDR organisms. Unfortunately, staff compliance with proven infection control measures, such as hand disinfection, is often poor and inconsistent. Staff education aimed at infection control must be inclusive, frequent, and reiterative. Special attention must be directed to house staff, students, volunteers, and visitors who may not be included in regularly scheduled infection control educational programs.
Continue reading

Preventing Ventilator-Associated Pneumonia in Adults: Addressing Barriers to Translating Guidelines Into Practice

Preventing Ventilator-Associated Pneumonia in Adults: Addressing Barriers to Translating Guidelines Into PracticeAs with other prevention efforts, interventions aimed at reducing VAP should focus on evidence-based interventions, for which efficacy and cost-effectiveness have been clearly supported by clinical studies and experts in the field (Table 1). Initially, it may be more prudent to focus on a limited number of feasible, cost-effective prevention strategies for VAP prevention. In the Institute for Healthcare Improvement (IHI) 100,000 Lives Campaign, hospitals are challenged to adopt as many of the six recommended initiatives to reduce health-care-associated infections. The VAP or “ventilator bundle” initiative includes five simple components: elevation of the head of the bed to between 30° and 45°, a daily “sedation vacation,” daily assessment for readiness to extubate, and prophylaxis for peptic ulcer disease and deep vein thrombosis. Some participating hospitals using this approach are reporting zero episodes of VAP over sustained periods of time (Donald Berwick, MD; IHI National Forum; personal correspondence; December 13, 2005). Confirmation of these dramatic results in peer-reviewed journals is eagerly anticipated.
Continue reading

Copyright © 2012 Medicine of the Future in America